160 related articles for article (PubMed ID: 10373428)
1. Characterization of the mouse sulfonylurea receptor 1 promoter and its regulation.
Hernández-Sánchez C; Ito Y; Ferrer J; Reitman M; LeRoith D
J Biol Chem; 1999 Jun; 274(26):18261-70. PubMed ID: 10373428
[TBL] [Abstract][Full Text] [Related]
2. Regulated expression of adenosine triphosphate-sensitive potassium channel subunits in pancreatic beta-cells.
Moritz W; Leech CA; Ferrer J; Habener JF
Endocrinology; 2001 Jan; 142(1):129-38. PubMed ID: 11145575
[TBL] [Abstract][Full Text] [Related]
3. Cloning of the promoters for the beta-cell ATP-sensitive K-channel subunits Kir6.2 and SUR1.
Ashfield R; Ashcroft SJ
Diabetes; 1998 Aug; 47(8):1274-80. PubMed ID: 9703328
[TBL] [Abstract][Full Text] [Related]
4. Disruption of sarcolemmal ATP-sensitive potassium channel activity impairs the cardiac response to systolic overload.
Hu X; Xu X; Huang Y; Fassett J; Flagg TP; Zhang Y; Nichols CG; Bache RJ; Chen Y
Circ Res; 2008 Oct; 103(9):1009-17. PubMed ID: 18802029
[TBL] [Abstract][Full Text] [Related]
5. Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53).
Gloyn AL; Hashim Y; Ashcroft SJ; Ashfield R; Wiltshire S; Turner RC;
Diabet Med; 2001 Mar; 18(3):206-12. PubMed ID: 11318841
[TBL] [Abstract][Full Text] [Related]
6. On potential interactions between non-selective cation channel TRPM4 and sulfonylurea receptor SUR1.
Sala-Rabanal M; Wang S; Nichols CG
J Biol Chem; 2012 Mar; 287(12):8746-56. PubMed ID: 22291026
[TBL] [Abstract][Full Text] [Related]
7. Transactivation of the mouse sulfonylurea receptor I gene by BETA2/NeuroD.
Kim JW; Seghers V; Cho JH; Kang Y; Kim S; Ryu Y; Baek K; Aguilar-Bryan L; Lee YD; Bryan J; Suh-Kim H
Mol Endocrinol; 2002 May; 16(5):1097-107. PubMed ID: 11981044
[TBL] [Abstract][Full Text] [Related]
8. Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain.
Chen M; Dong Y; Simard JM
J Neurosci; 2003 Sep; 23(24):8568-77. PubMed ID: 13679426
[TBL] [Abstract][Full Text] [Related]
9. The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide.
Sunaga Y; Gonoi T; Shibasaki T; Ichikawa K; Kusama H; Yano H; Seino S
Eur J Pharmacol; 2001 Nov; 431(1):119-25. PubMed ID: 11716850
[TBL] [Abstract][Full Text] [Related]
10. Burst kinetics of co-expressed Kir6.2/SUR1 clones: comparison of recombinant with native ATP-sensitive K+ channel behavior.
Alekseev AE; Kennedy ME; Navarro B; Terzic A
J Membr Biol; 1997 Sep; 159(2):161-8. PubMed ID: 9307442
[TBL] [Abstract][Full Text] [Related]
11. Alternative sulfonylurea receptor expression defines metabolic sensitivity of K-ATP channels in dopaminergic midbrain neurons.
Liss B; Bruns R; Roeper J
EMBO J; 1999 Feb; 18(4):833-46. PubMed ID: 10022826
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a novel member of the ATP-sensitive K+ channel subunit family, Kir6.3, in zebrafish.
Zhang C; Miki T; Shibasaki T; Yokokura M; Saraya A; Seino S
Physiol Genomics; 2006 Feb; 24(3):290-7. PubMed ID: 16317080
[TBL] [Abstract][Full Text] [Related]
13. Transgenic overexpression of SUR1 in the heart suppresses sarcolemmal K(ATP).
Flagg TP; Remedi MS; Masia R; Gomes J; McLerie M; Lopatin AN; Nichols CG
J Mol Cell Cardiol; 2005 Oct; 39(4):647-56. PubMed ID: 16099470
[TBL] [Abstract][Full Text] [Related]
14. Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel.
Ashfield R; Gribble FM; Ashcroft SJ; Ashcroft FM
Diabetes; 1999 Jun; 48(6):1341-7. PubMed ID: 10342826
[TBL] [Abstract][Full Text] [Related]
15. Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.
Winkler M; Stephan D; Bieger S; Kühner P; Wolff F; Quast U
J Pharmacol Exp Ther; 2007 Aug; 322(2):701-8. PubMed ID: 17495126
[TBL] [Abstract][Full Text] [Related]
16. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
Gribble FM; Tucker SJ; Seino S; Ashcroft FM
Diabetes; 1998 Sep; 47(9):1412-8. PubMed ID: 9726229
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of Kir6.2-SUR1 currents, in the absence and presence of sodium azide, to the K(ATP) channel inhibitors, ciclazindol and englitazone.
McKay NG; Kinsella JM; Campbell CM; Ashford ML
Br J Pharmacol; 2000 Jun; 130(4):857-66. PubMed ID: 10864893
[TBL] [Abstract][Full Text] [Related]
18. Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy.
Shyng SL; Ferrigni T; Shepard JB; Nestorowicz A; Glaser B; Permutt MA; Nichols CG
Diabetes; 1998 Jul; 47(7):1145-51. PubMed ID: 9648840
[TBL] [Abstract][Full Text] [Related]
19. Sulfonylurea receptor -1 (SUR1): genetic and metabolic evidences for a role in the susceptibility to type 2 diabetes mellitus.
Reis AF; Velho G
Diabetes Metab; 2002 Feb; 28(1):14-9. PubMed ID: 11938023
[TBL] [Abstract][Full Text] [Related]
20. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.
Dörschner H; Brekardin E; Uhde I; Schwanstecher C; Schwanstecher M
Mol Pharmacol; 1999 Jun; 55(6):1060-6. PubMed ID: 10347249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
